What's happening
On May 21, 2026, the US Department of Commerce announced letters of intent to deploy $2.013 billion in CHIPS Act research and development funding across nine quantum computing companies, with the federal government receiving minority non-controlling equity stakes in each firm in return. The structure mirrors venture-style investing, with government stakes ranging from approximately 1% — as in the case of GlobalFoundries, which is set to receive $375 million — to comparable minority positions across the other recipients. Secretary of Commerce Howard Lutnick framed the move in a statement: 'With today's CHIPS Research and Development investments in quantum computing, the Trump administration is leading the world into a new era of American innovation.'
IBM is the program's largest single beneficiary, designated to receive $1 billion in federal incentives to capitalize a new subsidiary named Anderon, which will focus on manufacturing quantum-grade superconducting wafers. IBM has committed an additional $1 billion of its own funds to the venture, bringing the total investment in that subsidiary to $2 billion. Among the smaller allocations, Rigetti Computing, D-Wave, and Infleqtion are each slated to receive approximately $100 million, while Diraq is set to receive up to $38 million. The investments are structured as letters of intent, meaning final terms and disbursements remain subject to negotiation and agreement.
Why it matters for markets
The $2.013 billion commitment represents one of the largest coordinated federal investments in quantum computing infrastructure to date, and its equity-stake structure marks a departure from traditional grant-based government R&D funding. By taking ownership positions rather than issuing non-recourse grants, the Department of Commerce introduces a mechanism through which taxpayers could theoretically share in the upside of commercial quantum breakthroughs — while also signaling a longer-term government interest in the sector's industrial development. IBM's 12% single-day share gain on the announcement, its largest since January 2025, reflected the scale of the commitment relative to IBM's existing quantum program and the $2 billion total capital mobilized for the Anderon subsidiary alone.
The targeted application areas — financial markets optimization, drug discovery, and cybersecurity — represent sectors where quantum advantage, if achieved, could have material economic consequences. For IBM, which carries a market capitalization of approximately $255.87 billion and annual revenue of $68.91 billion, the Anderon foundry positions the company as a potential supplier of quantum-grade superconducting wafers not only for its own systems but potentially for the broader industry. The government's willingness to accept a roughly 1% stake in GlobalFoundries in exchange for $375 million also establishes a pricing reference point for how equity stakes are being valued across the program, though terms vary by recipient.
Sectors and assets to watch
IBM (NYSE: IBM) is the central ticker to monitor given its $1 billion federal allocation and matching internal commitment to the Anderon quantum foundry subsidiary. With a 52-week range of $212.34 to $332.46 and a current market capitalization of $255.87 billion, IBM's quantum strategy now carries explicit government backing at a scale that distinguishes it from peers. The Anderon subsidiary's focus on superconducting wafer manufacturing could position IBM within the quantum supply chain in a role analogous to a foundry, separate from its existing quantum computing hardware and cloud services businesses.
IonQ (NYSE: IONQ), which was not named among the nine CHIPS Act recipients in the May 21 announcement, operates in the same quantum computing sector but via trapped-ion hardware architecture rather than superconducting qubits — the technology underpinning IBM's Anderon foundry. With a market capitalization of $21.59 billion, revenue of $187.1 million, and cloud-based quantum access partnerships with Amazon Braket, Microsoft Azure, and Google Cloud, IonQ represents the publicly traded pure-play quantum computing company most directly affected by shifts in sector sentiment and federal funding priorities. Other named recipients — Rigetti Computing, D-Wave, and Infleqtion — are also participants in the public or private quantum computing market and will warrant monitoring as their individual letters of intent progress toward finalized agreements.
What to watch next
Key developments to monitor include the conversion of letters of intent into binding agreements for all nine recipients, which will determine final equity stake percentages, disbursement schedules, and any performance or milestone conditions attached to the funding. The formal establishment and capitalization timeline of IBM's Anderon subsidiary will be a near-term indicator of execution progress. Congressional and regulatory scrutiny of the equity-stake model — a novel structure for CHIPS Act deployments — could affect the program's pace or scope. Additionally, whether other quantum hardware architectures, including trapped-ion systems, receive future tranches of government investment under similar or alternative programs will be a defining question for the competitive landscape among publicly traded quantum computing companies.